Antidepressant prescriptions may reduce the risk of testing positive for COVID-19

FHS
June 21, 2023
3:21 am

New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that community mental health patients who were prescribed antidepressants were significantly less likely to test positive for COVID-19 when admitted to inpatient care.

InvaGen recalls seizure treatment due to leaking sachets

Share this article The product is sold in foil pouches with each sachet containing a 500mg dose of Vigabatrin. Credit: PeopleImages.com – Yuri A /

December 11, 2023

Belumosudil mesylate by Sanofi for Lung Transplant Rejection: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 18, 2024

California’s Latest Psychedelics Bill Dies in Committee – Psychedelic Alpha

Despite efforts by the bill’s authors and advocates to play to the tune of state and national politics, this latest attempt at psychedelic policy reform

May 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.